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In Saccharomyces cerevisiae, the heat shock transcription factor
(HSF) is thought to be a homotypic trimer that is bound to the
promoters of heat shock protein (HSP) genes at both normal and
heat shock temperatures. Exposure to heat shock greatly and
rapidly induces HSF transcriptional activity without further increas-
ing DNA-binding affinity. It is believed that HSF is under negative
regulation at normal growth temperatures, but the detailed mech-
anism by which HSF is activated is still not clear. We report the
analysis of mutations in a conserved arginine (residue 274) at the
C-terminal end of the DNA-binding domain (DBD). Two mutations
significantly increase both basal activity of HSF at normal temper-
atures and induced activity on heat shock. We demonstrate by
coimmunoprecipitation experiments that the mutations reduce the
association between the DNA-binding domainoligomerization
domain and the transcription activation domains. Our studies
suggest that the DNA-binding domain of HSF can interact with
activation domains directly, and this interaction is important for
the repression of HSF activity under normal growth conditions.
Destabilizing this interaction by heat or by mutations results in HSF
transcriptional activation. We propose that Arg-274 is critical for
intramolecular repression of HSF activity in normally growing cells.
Eukaryotic cells respond to heat shock and other physiologicalstresses by dramatically increasing the expression of a spe-
cific set of genes encoding the heat shock proteins (HSPs; for
reviews, see refs. 1 and 2). The promoters of these genes possess
a cis-acting heat shock element (HSE) that consists of multiple
inverted, tandem repeats of the consensus sequence AGAAn,
where n can be any nucleotide (3, 4). The heat shock transcrip-
tion factor (HSF), which binds specifically to HSEs and regulates
the heat shock response, has been identified in yeast (5–7),
Drosophila (8), human (9), and many other organisms (1).
In the budding yeast Saccharomyces cerevisiae, ScHSF is
required for both growth at normal temperatures and viability on
stress. In fact, ScHSF is bound to DNA at all temperatures, and
heat shock converts the DNA-bound transcriptionally weak
ScHSF into a highly active factor (10, 11). Although on heat
shock the ScHSF shows some increased binding to secondary,
low-affinity HSEs, the overall effect on DNA binding is insig-
nificant and thus not likely to be an important regulatory step in
ScHSF activation (12, 13). Other mechanisms, such as phos-
phorylation and (or) dephosphorylation, that modify the activity
of the transcription activation domains, are more likely to be
involved in the activation process (6, 11, 14, 15). Point mutation
and deletion studies show that most mutations in ScHSF cause
an increase in the constitutive transcriptional activity (10, 16–
18), indicating that ScHSF is probably under negative regulatory
control in the absence of stress.
The functional domains of HSFs have been well characterized.
All HSFs from different species contain two conserved domains:
a winged helix–turn–helix DNA binding domain (DBD) (19) and
a trimerization domain consisting of an -helical coiled-coil
motif (20, 21). Apart from these two domains, homology com-
parisons reveal no other significant conservation in the activa-
tion domains of HSFs. By deletion mapping and analysis of
chimeric proteins containing HSF sequences fused to heterolo-
gous DNA-binding domains, three ScHSF activation domains
were identified. The activation domain II (AII, residue 410–648)
is essential for growth during heat shock but not for normal
conditions. The roles of activation domain I (AI, residue 1–172)
and activation domain III (AIII, residue 589–833) were not clear
when they were first identified by Nieto-Sotelo et al. (10),
because AIII is dispensable for viability at both normal and
stress-temperatures. Later studies showed that the AI domain
probably functions in non-shocked cells to allow viability and is
responsible for transient activity, whereas the AIII domain is
probably responsible for sustained activities at increased tem-
perature (11). All three activation domains are constitutively
active when fused to yAP-1 DNA-binding domain (10). Mech-
anisms of repression at normal growth temperatures remain
unknown; however, some evidence suggests that activation do-
mains are restrained by the DNA-binding domain and trimer-
ization domain (10). Deletions of certain residues in the DNA-
binding domain increase the overall activity of HSF, indicating
that DNA-binding domain may play an important regulatory
role in addition to HSE recognition. However, it is not clear that
the DNA-binding domain represses ScHSF activity through
direct intramolecular interactions with activation domains, or
perhaps indirectly with the association of another member of
heat shock response circuitry, such as HSP70 or HSP90.
In this paper, we report experiments dealing with a key
arginine residue (R274) and its role in HSF regulation. Arg-274
is a highly conserved residue located at the C-terminal end of the
HSF DNA-binding domain (1). We show that two mutations
significantly increase both constitutive activity of HSF at normal
temperatures and induced activity on heat shock. In addition,
coimmunoprecipitation experiments reveal that the DBD will
bind to all three activation domains and that mutations in
Arg-274 reduce this association. Our studies suggest that DNA-
binding domain of HSF can interact with activation domains
directly, and this interaction is important for the repression of
HSF activity under normal conditions.
Materials and Methods
Yeast Strains. The haploid yeast strain, pYES-URA, in which
chromosomal loci of HSF were disrupted, was used. This hsf
strain contains an episomal copy of HSF whose transcription is
controlled by the GAL1,10 promoter (5).
Plasmid Constructions and Protein Expression. The shuttle vector
used in this work, pYES2-FHC, is a 2-based high copy plasmid,
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with FLAG epitope and six-His tag at C-terminal, and with
either TRP1 or URA3 selection (22). Expression vector
pGEX-2t was used to make glutathione S-transferase (GST)-
fusion recombinant proteins. The fusion proteins were expressed
in Escherichia coli strain BL21(DE3), and purified with GST
affinity resin (Stratagene). The GST-fusion proteins were eluted
with 100 mM reduced glutathione in 50 mM Tris (pH 8.0), 0.5
M NaCl, and 1% Triton X-100. Expression vector pCAL-n was
used to make calmodulin-binding peptide (CBP)-fusion proteins
(Stratagene), and the recombinant proteins were purified by
calmodulin affinity resin (Stratagene).
Mutagenesis. Desired mutant oligos were annealed to single-
stranded dU DNA. The mixture was heated to 70°C, and slowly
cooled to room temperature. Second strand was synthesized by
adding T4 DNA polymerase and T4 DNA ligase. Sequencing of
the plasmids confirmed that only the desired mutations were
introduced. All of the mutant HSFs were cloned into pYES2-
FHCTRP plasmid with BamHI and XhoI sites, and were
selected by SG-TRP  URA  5-FOA plate.
Transformations. Yeast cells were transformed by using ALKALI-
CATION Yeast Transformation Kit from Bio 101. The protocols
are based on lithium acetate procedure.
Yeast Cell Extract Preparation and Western Blotting. Yeast whole cell
extracts were prepared according to Schultz et al. (23). Western
blotting analysis was performed with about 100 g of whole cell
extract and anti-FLAG M2 antibody (Eastman Kodak). The
immune complexes were visualized by AP (alkaline phos-
phatase)-based chromogenic method.
Total RNA Isolation and Primer Extension Analysis. Total RNA from
control (25°C) and heat-shocked cells (40°C) was isolated by
using RNAqueous Total RNA Isolation Kit from Ambion
(Austin, TX). Five nanograms of 5 end-labeled oligonucleotides
(described below) were hybridized to 58 g of total RNA in TE
(10 mM TrisCll mM EDTA, pH 7.4) containing 200 mM KCl.
Total final volume was adjusted to 12 l. The oligonucleotides
were annealed by heating the reaction mixture at 65°C for 30
min, followed by gradual cooling to room temperature. Then
avian myeloblastosis virus (AMV) reverse transcriptase was
added to the annealing product, and the reaction mixture was
incubated at 42°C for 1 h. The samples were electrophoresed on
denaturing 8 M urea-6% polyacrylamide gels. Dried gels were
exposed to Molecular Dynamics PhosphorImager plates, which
were then scanned on the Molecular Dynamics ImageQuant.
The oligonucleotides used for primer extension analysis are as
follows: SSA4, 5-AGCATCGTTCGTCACTTCTGGATCA-3;
and actin, 5-CCGGCTTTACACATACCAGA-3.
In Vitro Cross-Linking Assay. To investigate the oligomerization of
wild-type and mutant DBDs, 1 g of GST-tagged DBDs was
cross-linked by addition of 2 mM 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS) to D buffer (25 mM Hepes, pH 7.4100 mM
KCl1 mM EDTA0.2% Triton X-100) and incubation for 30
min at 25°C. The reactions were quenched by the addition of
lysine to 20 mM, and analyzed by 8% SDSPAGE. Western
blotting was then performed by using anti-GST antibody (Am-
ersham Pharmacia), and molecular weight markers (Bio-Rad)
were used to determine the approximate sizes of the complexes.
Mobility-Shift Assay. Mobility-shift assay was performed by using
the HSE-containing fragment as the follows: wild-type HSE,
GCGCGCCTCGAATGTTCGCGAAAAGA; mutant HSE,
GCGCGCCTCGAATGGGCGCGAAAAGA. GAA repeats are
shown in bold, and mutated nucleotides in mutant HSE are
underlined. Binding assay buffer contains 250 gml BSA, 100
gml poly(dIdC), and 4% Ficoll. -32P-labeled HSEs or un-
labeled HSE were incubated with 1 g of wild-type or mutant
DBDs at room temperature for 20 min, and the reaction
complexes were analyzed by 5% acrylamide0.5 TBE gel.
Coimmunoprecipitation Assay. To investigate the interactions be-
tween DBDs and activation domains, CBP-tagged activation
domains were labeled with [-32P]ATP by protein kinase A
(PKA). GST-tagged wild-type and mutant DBDs were immo-
bilized by anti-GST antibody-coupled protein G Sepharose
(Amersham Pharmacia), then incubated with [-32P]AI, -AII, or
-AIII (50,000 cpml) for 30 min at 25°C. After 3 washes with
D buffer containing 0.5 M NaCl and 0.5% Triton X-100, the
precipitates were resuspended in SDS loading buffer and ana-
lyzed by 12% SDSPAGE and autoradiography.
Results
Effect of a DNA-Binding Domain Mutation on Heat Shock Factor
Activity. By mutagenesis of ScHSF, we isolated a temperature-
sensitive mutant that is viable only at room temperature and
30°C, but not at 37°C (Table 1). Sequence analysis showed that
a mutation in the DBD of HSF had occurred. The original
sequence Arg-Gln-Lys (amino acid 274–276) was altered to
Ser-Gln-Gln-His-Ala. This mutant was designated dbd-mut.
To compare the transcriptional activities of wild-type and
dbd-mut HSFs, the levels of specific HSP gene transcription were
analyzed. Transcriptional activities of wild-type and dbd-mut
HSFs were determined by directly measuring the level of mRNA
transcription from SSA4, the major HSP70-inducible gene, by
primer extension. Actin mRNA was monitored simultaneously
as an internal control. Surprisingly, although the transcription of
SSA4 in wild-type cells was not detectable under non-shock
conditions, in the dbd-mut cells, SSA4 was actively transcribed at
control temperature (25°C; Fig. 1A, lane 4). In addition, the
activity of this mutant ScHSF can be further induced by heat
shock: the transcription level of SSA4 in dbd-mut cells is about
three times higher than that of wild-type cells at heat shock
temperature (40°C; determined by PhosphorImager analysis,
Fig. 1, compare lanes 2 and 5). During recovery from heat shock,
wild-type cells recover significantly quicker than the dbd-mut
cells (data not shown). Whereas in wild-type cells SSA4 is not
detectable 60 min after heat shock, in dbd-mut cells, SSA4
transcription returns to pre-heat shock levels.
The drastically increased HSP70 expression might account for
the lethality of this mutant at heat shock temperatures. It has
been reported before that elevated level of Hsp70 can impede
cell growth and division (24). With activation of the HS response,
normal protein synthesis is suspended, and protective HSPs are
produced that rescue the heat-denatured proteins. But cell
survival is achieved at the expenses of normal growth and
development, presumably because HS response takes prece-
dence over other developmental events and alters the normal
programs of gene activity (24). The hyperactive dbd-mut HSF
could potentially disrupt the expression of essential housekeep-
ing genes and cause cell death.
Arginine 274 Is Important for Negative Regulation of Heat Shock
Factor’s Transcription Activity. Among the amino acids altered in
dbd-mut ScHSF, arginine 274 is a highly conserved residue
Table 1. Phenotypes of yeast cells expressing mutant ScHSFs
Wild type dbd-mut R274 K R274 G R274 E
25°     —
30°     —
37°  —   —








present in HSFs from many different species (1). The crystal
structure of Drosophila melanogaster HSF’s DNA-binding do-
main shows that Arg-274 is located in a flexible linker region at
the very end of the C terminus. Arg-274 is about 20 residues
downstream of the 4 strand, and probably not directly involved
in DNA binding. To analyze the specific functional significance
of Arg-274, three site-directed mutants were created: R274K,
R274G, and R274E, in which the Arg was changed to positively,
neutrally, and negatively charged residues, respectively. To study
the properties of these mutant HSFs, we used a yeast strain
carrying a disrupted chromosomal HSF locus. HSF is an essen-
tial gene in yeast, so the strain with a disrupted chromosomal
HSF was kept viable with a HSF gene carried on a URA3-
containing vector. This strain was transformed with mutant
ScHSFs cloned in a TRP1-based plasmid. Selection on 5-fluo-
roorotic acid allowed the loss of the URA3-containing wild-type
ScHSF plasmid, leaving cells with only mutant ScHSF on the
TRP1 vector.
R274E mutant is completely lethal; all of the cells died after
plating onto 5-FOA plates. R274G mutant grows normally at
30°C but has a slightly slower growth rate at 37°C, whereas
R274K mutant exhibits wild-type phenotype (Table 1). Primer
extension analysis of HSP70 shows that the transcriptional
activity of the R274K mutant HSF is properly regulated by
temperature (Fig. 1 A, lanes 7–9). On the other hand, although
R274G mutant does not show growth defects, the activity of
R274G-HSF is higher than that of wild type both at non-shock
(25°C) and heat shock (39°C) temperatures (Fig. 1 A, lanes
9–12). The abnormal behavior of dbd-mut and R274G HSF
demonstrate that Arg-274 is very important for the negative
regulation of HSF activity. Without the positive charge at this
position, the activity of ScHSF is significantly elevated at control
temperatures.
The viability of the mutant strains correlates with the severity
of the mutations. The presence of a negatively charged residue
probably destabilizes the conformation of HSF significantly,
causing cell death. On the other hand, R274G is a relatively mild
alteration. PhosphorImager quantitation shows that SSA4
mRNA level in heat-shocked R274G mutant cells is about half
as much as in heat-shocked dbd-mut cells. Yeast cells may be able
to tolerate moderately high levels of HSP70 expression, resulting
in a slightly slower growth rate.
To rule out the possibility that different levels of HSP70
transcription are due to different levels of HSF expression,
Western blotting analysis was used to detect the expression of
HSF in wild and mutant cells. Equal levels of HSF were
expressed in all these cells (Fig. 1B), indicating that it is the
Arginine 274 mutation that activates HSF under non-shock
temperatures.
The transcriptional activities of mutant HSFs were also in-
spected by -galactosidase enzyme activity assays by using a
yeast strain transformed with (HSE)4LacZ reporter gene (data
not shown). The results confirmed that dbd-mut and R274G
HSFs have higher activity both at non-shock and heat shock
temperatures, whereas the R274K HSF mutant was very similar
to wild type.
Mutation of Arginine 274 Causes a Reduction in DNA Binding Affinity.
One possible explanation for the hyperactivity of dbd-mut and
R274G HSF is increased DNA-binding affinity. Although sev-
eral earlier studies have shown that the level of DNA binding
does not correlate with transcription levels before or after heat
shock (2), it was important to measure the DNA binding
affinities of mutant HSFs. Wild-type and mutant HSFs from
residues 167 to 424 (including the DNA-binding domain and the
helical oligomerization domain; Fig. 4A) were fused to a GST-
tag, and the recombinant proteins were purified by GST-affinity
chromatography (Stratagene). As determined by gel mobility
shift assays, all four recombinant DBDs bind to 32P-labeled-HSE
sequence (Fig. 2, lanes 1, 6, 11, and 16), but none of the examined
recombinant DBDs bound to 32P-labeled-mutant HSE, in which
the nGAAnnTTCn consensus was mutated to nGGAnnGGCn
(lanes 5, 10, 15, and 20). In addition, binding to [32P]HSE is
effectively competed away by unlabeled HSE (Fig. 2, lanes 4, 9,
14, and 19), demonstrating the specificity of wild-type HSE
recognition by recombinant DBDs. Interestingly, we observed
that the wild-type DBD has the highest affinity for HSE (lanes
1–3); R274G also exhibits high DNA-binding affinity, but is
slightly lower than wild type. Both the dbd-mut and R274E show
Fig. 1. Transcriptional activities of mutant HSFs. (A) Transcriptional activities
of wild-type and mutant ScHSFs are measured by levels of HSP70 mRNA by
using primer extension. Primer extension products are indicated (HSP70,
309–313 nucleotides; actin, 198–200 nucleotides). Lanes 1–3, wild-type HSF;
lanes 4–6, dbd-mut HSF; lanes 7–9, R274K HSF; lanes 10–12, R274G HSF. NS,
non-shock, cells grown at 25°C. HS, heat shock, cells subjected to heat shock at
40°C for 30 min. R, recovery, cells put back to 25°C for 1 h after heat shock to
allow recovery. (B) Western blotting analysis of wild-type and mutant HSF
proteins. Yeast cell extracts were subjected to SDSPAGE and transferred to
nitrocellulose filter. The protein blot was probed with anti-FLAG antibody
(Sigma) fused to the C terminus of HSFs.
Fig. 2. DNA-binding assay. Gel mobility shift assay of wild-type and mutant
DBDs to labeled HSE is shown. A mutant HSE with nGAAnnTTCn repeats
changed to nGAAnnGGCn was also used to ensure binding specificity (lanes 5,
10, 15, and 20). Increasing amounts of unlabeled HSE were added for com-
petition assay. The numbers shown at the bottom of each lane are the ratios
of unlabeled HSE to [32P]HSE. Major DBD–HSE complexes are shown by the
lower arrow. Mutant DBDs also form higher-order complexes (upper arrow).
Note that microgram quantities of HSFs are used in these experiments because
the recombinant proteins bind to the HSE less well than the native HSF.
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a significant decrease in HSE binding affinity. This result clearly
demonstrates that the derepression observed by the mutant
HSFs is not due to an increased DNA binding activity. Further-
more, from the structural information available on the Drosoph-
ila HSF and Kluyveromyces lactis HSF, R274 does not interact
with the DNA directly (1, 25); therefore, the decreased DNA-
binding affinity must result from secondary effects of R274
mutations.
In addition to the major DNA–protein complex, mutant DBDs
and HSE also form higher molecular weight complexes (Fig. 2,
lanes 6, 11, and 16, upper arrow). This high molecular weight
complex is not seen in wild-type DBD–DNA complex. To
examine the molecular interaction causing the higher molecular
weight complex, wild-type and mutant DBDs were cross-linked
in the absence of DNA and analyzed by SDSPAGE. Western
blotting analysis of cross-linking products of DBDs shows that
wild-type DBD exists in an equilibrium of monomers, dimers,
and trimers (Fig. 3, lane 1), whereas dbd-mut and R274E exist
predominantly as trimers and hexamers (lanes 2 and 4, based on
their apparent molecular weight). Monomer forms of these two
DBDs are almost absent. The oligomerization state of R274G is
in between, with all four forms present (lane 3). This result
provides additional evidence that Arg-274 mutation causes the
overall conformational changes of DBD and oligomerization
domain, and this conformational change leads to a greater
tendency to form high molecular weight oligomers. It is likely
that mutation of the arginine perturbs the organization of
oligomerization domain, increasing the tendency of HSF to form
either high molecular weight oligomers or an alternate trimer
conformation, perhaps reflecting an ‘‘activated’’ state.
DNA-Binding Domains of Mutant ScHSFs Have Reduced Affinity to the
Activation Domains. Previous deletion studies of ScHSF have
revealed the presence of certain functional domains (Fig. 4A; ref.
10), including a DNA-binding domain, a helical oligomerization
domain, and three transcription activation domains, AI, AII, and
AIII, whose activities are repressed at normal temperatures. It
has been reported that DNA-binding domain may play an
important regulatory role of repressing transcriptional activation
in addition to its obvious role in mediating DNA binding (16, 22).
Many mutations in DNA binding domain increase HSF’s activity
without enhancing the DNA binding properties. For example, a
M232V mutation of ScHSF has a constitutively activating phe-
notype (16).
The hyperactivity exhibited by dbd-mut and R274G ScHSFs
suggests that, under normal conditions, activation domains of
HSF are probably masked by the DNA-binding and oligomer-
ization domains. In case of these two mutated ScHSFs, loss of the
positively charged Arg causes the derepression of the activation
domains. To study the physical interactions between activation
domains and DNA-binding domain, we separately cloned
the AI (residue 1–172), AII (residue 410–648), AIII (residue
589–833), and DNA-binding and oligomerization domains
(DBD, residue 167–424) into different prokaryotic expression
vectors, and examined the interactions between them by
immunoprecipitation.
Wild-type and mutant DBDs were fused to GST-tag and
purified as described before, and then immobilized by anti-GST
antibody coupled to protein G Sepharose. AI, AII, and AIII
were fused to CBP-tag, and the recombinant AI, AII, and AIII
were purified through calmodulin-coupled chromatography. Pu-
rified activation domains were labeled in vitro with PKA and
[-32P]ATP at a PKA target sequence within the CBP. The AI,
AII, and AIII were incubated with immobilized wild-type and
mutant DBDs, and the precipitated products were analyzed by
SDSPAGE. Fig. 4B shows that HSF DBD binds to all three
activation domains. The wild-type DBD showed the highest level
of association with the activation domains compared with the
mutant DBDs (Fig. 4B, lanes 2, 7, and 12). The binding prop-
erties of the mutant DBDs to the activation domains correspond
well with their phenotypes and transcription activities. The DBD
derived from the lethal mutant R274E demonstrated the lowest
level of binding to all three activation domains, whereas R274G
is only moderately less able to bind AII and AIII than is
Fig. 3. Oligomerization state of wild-type and mutant HSFs. One microgram
of recombinant wild-type and mutant DBDs was cross-linked by DSS and
analyzed by Western blotting analysis. Wild-type DBD exited as an equilibrium
of monomer, dimer, and trimer (lane 1). Mutant DBDs also formed hexamer
(lanes 2, 3, and 4).
Fig. 4. Binding affinities between DNA-binding domain and activation
domains correlate with HSF transcriptional activities. (A) Schematic diagram of
domain organization of S. cerevisiae HSF. Amino acid endpoints for each
region, as well as their proposed functions, are indicated. (AI, AII, and AIII
represent three constitutive activation domains. DBD, DNA-binding domain;
IRL, isoleusine repeat (oligomerization domain). This diagram is adapted from
the work of Nieto-Sotelo et al. (10). (B) Coimmunoprecipitation of activation
domains with wild-type and mutant DBDs. Recombinant wild-type and mu-
tant DBDs were immobilized by anti-GST antibody-coupled protein G Sepha-
rose. Recombinant activation domain I (AI), activation domain II (AII), and
activation domain III (AIII) were labeled with [-32P]ATP and PKA catalytic
subunit. 32P-labeled AI (lanes 1–5), AII (lanes 6–10), and AIII (lanes 11–15) were
precipitated by immobilized DBDs. Equal amounts of anti-GST antibody-
coupled protein G Sepharose without DBD were used as control to assess
nonspecific interactions (lanes 1, 6, and 11). (C) Western blotting analysis of
immobilized wild-type and mutant DBDs used in coimmunoprecipitation.








wild-type DBD. Fig. 4C shows that the same amounts of DBDs
were used in these experiments. These coimmunoprecipitation
results confirm the idea that DBD interacts with the activation
domains, and these interactions may be important for the
repression of HSF activity at non-shock temperatures.
Considering the fact that three Arg-274 mutations lowered the
binding affinities for all three activation domains, this residue
may be important for maintaining the overall structure of the
DBD and oligomerization domain, but probably does not me-
diate specific interactions between the DBD and the activation
domains. Circular dichroism studies of DBD show that Arg-274
is within a flexible linker region without any ordered secondary
structure (26). It has been suggested that this linker region might
be important to adjust the 3-fold symmetric HSF trimers to the
180° symmetry between inverted HSE repeats. So it is likely that
loss of the positively charged Arg-274 causes some overall
conformational changes of DBD and oligomerization domain,
resulting in the decreased association with the activation
domains.
dbd-mut HSF Is Activated at a Slower Rate than Wild-Type HSF and
May Be Analogous to Partially Activated HSF. The kinetics of ScHSF
activation suggest that dbd-mut ScHSF may already be in the
active conformation mimicking activated ScHSF. Fig. 5 shows
the transcription of SSA4 when wild-type and dbd-mut cells were
heat shocked for 0 min, 5 min, 10 min, 15 min, 30 min, and 3 h,
respectively. The induction of SSA4 transcription is very rapid in
wild-type cells. The amount of SSA4 mRNA is greatly increased
after 5 min of heat shock, and reaches peak level only after 15
min of heat shock. Beyond 15 min, SSA4 transcription is
maintained at a stable level (Fig. 5A, lanes 1–4). Long periods
of heat shock (3 h, lane 5) decrease SSA4 transcription, probably
because expression of HSP70 negatively regulates HS response
(27). In contrast, 5 min of heat shock did not induce further
activation of dbd-mut HSF at all (lane 7). mRNA level of SSA4
remains unchanged. This observation suggests that dbd-mut
mimics an activated HSF, so short-term heat shock will not
further increase its transcriptional activity. Longer periods of
heat shock (15 and 30 min, lanes 8 and 9) probably thermally
destabilize the structure of dbd-mut HSF, causing further expo-
sure of activation domains, and in turn the further activation of
mutant HSF. Three hours of heat shock cause massive death of
mutant cells, which can be observed from the obviously de-
creased transcription of actin (lane 10). The kinetics of tran-
scriptional activation were further examined by PhosphorImag-
ing, and the results were plotted in Fig. 5B. The ratios of SSA4
transcription to actin are displayed as a function of time. Clearly,
the wild type responds rapidly and peaks at 15 min. The dbd-mut
does not show the initial increase in transcription; rather, a
delayed stimulation is observed at 10 min.
Discussion
The activation domains of ScHSF are repressed in non-stressed
cells. It is known that sequences present in the DBD, oligomer-
ization domain, and a short conserved element, CE2, are re-
quired to maintain repression (1). Within the DNA-binding
domain of ScHSF, mutation of residue M232 to V results in
constitutive activation at non-stress temperatures (16). In this
report, we show that mutation of R274, located in a solvent-
exposed position of the linker region between DNA-binding
domain and oligomerization domain, leads to derepression at
normal growth temperature. These conserved residues must play
an important role in the maintenance of the inactive state of the
transcription factor.
Although not directly involved in DNA binding, Arginine 274
is highly conserved and found in K. lactis HSF, Schizosaccharo-
myces pombe HSF, Arabidopsis thaliana HSF, Drosophila HSF,
mouse HSF12, and human HSF12 (1). Our results demon-
strate that a conservative change of Arg-274 to lysine has little
effect on ScHSF transcriptional activity. In contrast, a mutation
that reverses that charge of R274 to glutamic acid results in
lethality. These observations suggest that the positive charge at
this position is important for normal activity of ScHSF. The
DBDs from dbd-mut and R274G mutants showed reduced
affinities for all three activation domains and tended to form
higher order structures. Overall, these observations suggest that
Arg-274 is critical for maintaining the inactive structure of
ScHSF, and mutations in this residue result in significant con-
formational changes. The portion of the DBD where Arg-274 is
located has no ordered secondary structure as determined by
circular dichroism (26). Therefore, despite the fact that Arg-274
is a highly conserved residue, it may be in a flexible portion of
ScHSF. The value of a flexible linker between the DBD and
oligomerization domain may be to assist DNA binding. If ScHSF
binds to DNA as a trimer, three DBDs would be rotated 120°
relative to each another. The HSEs however, are palindromic
repeats with 180° symmetry. The linker region perhaps maintains
the correct positioning of the DBD and oligomerization domain,
so that a trimer can fit into HSEs (28). Without a positive charge
at residue 274, as seen with the mutants described in this paper,
the correct positioning of DBD and oligomerization domain
might be disturbed, and the mutants cannot bind to DNA with
high affinity.
The structural integrity of the DBD and the oligomerization
domain seems to be very important for their negative regulatory
functions. Recent work from Hardy et al. (28) showed that
Fig. 5. Kinetics of wild-type and dbd-mut HSF activation. (A) Primer exten-
sion analysis of the activation kinetics of wild-type and dbd-mut HSFs. Cells
were harvested after 0, 5, 15, 30, or 180 min of heat shock, and HSP70 mRNA
levels were measured by primer extension. Actin mRNA was measured at the
same time as internal control. dbd-mut HSF (lanes 6–10) is activated slower
than wild type (lanes 1–5). (B) Kinetics plot of wild-type and dbd-mut HSFs
activation. The units are arbitrary. The ratio of HSP70 mRNA transcription to
actin mRNA transcription at 5 min of heat shock in wild-type cells was set to
1, and all of the other quantitative data (obtained from PhosphorImager
plate) were normalized accordingly. The x axis is drawn logarithmically. The
transcriptional activities of dbd-mut HSF after 30 min of heat shock were not
shown, because progressive cell death caused inaccurate measurement.
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deletions of conserved residues within an -helical bulge in DBD
increases the overall activity of ScHSF, but when these con-
served residues were mutated, there was little effect observed.
This result demonstrates that the presence of a bulge in DBD,
rather than specific residues, is critical for the negative regula-
tion. Similarly, structural disturbance resulted from Arg-274
mutation can account for the reduced affinities for activation
domains and increased HSF transcriptional activities. Unfortu-
nately, without the structural information of the full-length HSF
trimer complexed with DNA, we do not know at this time the
detailed function of this arginine.
It has been shown that human HSF1 purified from HeLa cell
extract can be activated by heat shock (29), and recombinant
mouse HSF1 can acquire DNA-binding on in vitro heat shock
(30). All these studies suggest that HSF may be capable of
sensing heat shock directly. Perhaps heat shock induces struc-
tural changes of HSF, especially within DBD and oligomeriza-
tion domain, destabilizing the interactions between DBD and
activation domains and thus increasing transcriptional activity.
The fact that the transcriptional activities of wild-type, dbd-mut,
and R274G ScHSFs correspond very well with their respective
affinities for activation domains supports this idea. dbd-mut and
R274G HSFs are activated even at 25°C. We suggest that this is
the result of a less tight association between the DBD and
activation domains. In other words, structural changes caused by
the Arg-274 mutation might mimic the structural changes in-
duced by heat shock.
We also demonstrated here that increased transcriptional
activity of mutant ScHSFs is not due to increased DNA-binding
affinity. A substantial amount of data already indicates that the
degree of DNA-binding does not correlate with transcriptional
activities of ScHSF. For example, SSA4, the major HSP70 in S.
cerevisiae, is expressed at extremely low level during steady-state
growth at 23°C, but its expression is greatly enhanced on upshift
to 39°C (31). However, no further increase in DNA-binding at
the SSA4 promoter was observed (32). In our case, although
dbd-mut showed reduced DNA-binding affinity compared with
wild type, its transcriptional activity, both at non-shock and heat
shock temperatures, was actually higher. This observation fur-
ther confirms that, at least for strong HSEs, like those present
in the SSA4 promoter, increased DNA-binding is not the major
regulatory process involving in HSF activation. In fact, confor-
mational changes and destabilization of certain intramolecular
interactions can even overcome the reduced DNA-binding af-
finity and activate HSF. For some promoters with weaker,
secondary HSEs, such as the HSP 82 promoter, heat shock does
lead to an increased occupancy of HSF, and the increased
DNA-binding contributes to the overall activation process. How-
ever, it is not likely that the moderate increase in DNA-binding
fully accounts for the very significant increase in transcriptional
activity. Therefore, derepression of the activation domains is
probably the most important mechanism involved in the activa-
tion process. Our results support the hypothesis that DNA-
binding domain of ScHSF has an important role in negative
regulation, and that the activation process involves a dynamic
dissociation of DBDoligomerization domain from the activa-
tion domains. While this manuscript was being evaluated, related
studies employing alanine-scanning mutations in the DBD of
ScHSF also demonstrate the interactions between the DBD and
the activation domains (33). Structural studies of full-length HSF
will provide insights that should demonstrate how mutation of
Arg-274 causes conformational changes of the DBD and oli-
gomerization domain.
We thank Dr. Xiangdong Fang for suggestions on protein purification.
We thank Dr. Duncan Odom for helpful comments on the manuscript.
This work was supported by National Institutes of Health Grant
GM47381 (to C.S.P.).
1. Wu, C. (1995) Annu. Rev. Cell Dev. Biol. 11, 441–469.
2. Mager, W. H. & Dekruijff, A. J. J. (1995) Microbiol. Rev. 59, 506–531.
3. Amin, J., Ananthan, J. & Voellmy, R. (1988) Mol. Cell. Biol. 8, 3761–3769.
4. Perisic, O., Xiao, H. & Lis, J. T. (1989) Cell 59, 797–806.
5. Wiederrecht, G., Seto, D. & Parker, C. S. (1988) Cell 54, 841–853.
6. Sorger, P. K. & Pelham, H. R. B. (1988) Cell 54, 855–864.
7. Jakobsen, B. K. & Pelham, H. R. B. (1991) EMBO J. 10, 369–375.
8. Clos, J., Westwood, J. T., Becker, P. B., Wilson, S., Lambert, K. & Wu, C. (1990)
Cell 63, 1085–1097.
9. Kingston, R. E., Schuetz, T. J. & Larin, Z. (1987) Mol. Cell. Biol. 7, 1530–1534.
10. Nieto-Sotelo, J., Wiederrecht, G., Okuda, A. & Parker, C. S. (1990) Cell 62,
807–817.
11. Sorger, P. K. (1990) Cell 62, 793–805.
12. Erkine, A. M., Magrogan, S. F., Sekinger, E. A. & Gross, D. S. (1999) Mol. Cell.
Biol. 19, 1627–1639.
13. Jakobsen, B. K. & Pelham, H. R. B. (1988) Mol. Cell. Biol. 8, 5040–5042.
14. Shi, Y. H., Kroeger, P. E. & Morimoto, R. I. (1995) Mol. Cell. Biol. 15,
4309–4318.
15. Hoj, A. & Jakobsen, B. K. (1994) EMBO J. 13, 2617–2624.
16. Bonner, J. J., Heyward, S. & Fackenthal, D. L. (1992) Mol. Cell. Biol. 12,
1021–1030.
17. Morimoto, R. I. (1998) Genes Dev. 12, 3788–3796.
18. Morano, K. A., Liu, P. C. C. & Thiele, D. J. (1998) Curr. Opin. Microbiol. 1,
197–203.
19. Vuister, G. W., Kim, S. J., Orosz, A., Marquardt, J., Wu, C. & Bax, A. (1994)
Nat. Struct. Biol. 1, 605–614.
20. Sorger, P. K. & Nelson, H. C. M. (1989) Cell 59, 807–813.
21. Peteranderl, R. & Nelson, H. C. M. (1992) Biochemistry 31, 12272–12276.
22. Sikorski, R. S. & Hieter, P. (1989) Genetics 122, 19–27.
23. Schultz, M. C., Choe, S. Y. & Reeder, R. H. (1991) Proc. Natl. Acad. Sci. USA
88, 1004–1008.
24. Edwards, M. J. (1998) Cell Stress Chaperones 3, 213–220.
25. Littlefield, O. & Nelson, H. C. M. (1999) Nat. Struct. Biol. 6, 464–470.
26. Flick, K. E., Gonzalez, L., Harrison, C. J. & Nelson, H. C. M. (1994) J. Biol.
Chem. 269, 12475–12481.
27. Morimoto, R. I., Sarge, K. D. & Abravaya, K. (1992) J. Biol. Chem. 267,
21987–21990.
28. Hardy, J. A., Walsh, S. T. R. & Nelson, H. C. M. (2000) J. Mol. Biol. 295,
393–409.
29. Larson, J. S., Schuetz, T. J. & Kingston, R. E. (1995) Biochemistry 34,
1902–1911.
30. Goodson, M. L. & Sarge, K. D. (1995) J. Biol. Chem. 270, 2447–2450.
31. Lindquist, S. & Craig, E. A. (1988) Annu. Rev. Genet. 22, 631–677.
32. Sorger, P. K., Lewis, M. J. & Pelham, H. R. B. (1987) Nature (London) 329,
81–84.
33. Bulman, A. L., Hubl, S. T. & Nelson, H. C. M. (2001) J. Biol. Chem. 276,
40254–40262.
Chen and Parker PNAS  February 5, 2002  vol. 99  no. 3  1205
BI
O
CH
EM
IS
TR
Y
